If you notice significant changes in appetite suppression, gastrointestinal effects, or weight loss trajectory after switching, document them and discuss with your provider
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Vitruvias Cyanocobalamin for Injection is administered as an injection by a healthcare professional and is available in a single-use vial containing 1 mL of the medication
Join us as we explore the fascinating BPC-157 peptide, its functions, and controversies
The Broad Institute, a genomic research center run by MIT and Harvard, maintains a database called the Connectivity Map that tracks how compounds shift gene expression across thousands of human cell lines